Leaflet VIDEX EC 250mg gastro-resistant capsules
Indicated for: HIV-1 infection
Route of administration: oral
Substance: didanosine (antiretroviral)
ATC: J05AF02 (Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Didanosine is an antiretroviral medication used to treat HIV-1 infection, usually in combination with other antiretroviral drugs. It belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs) and works by blocking the enzyme necessary for HIV replication.
The medication is taken orally, usually once or twice daily, on an empty stomach, as directed by a doctor.
Side effects may include nausea, diarrhea, abdominal pain, or peripheral neuropathy. In rare cases, severe adverse effects such as pancreatitis or lactic acidosis may occur.
Patients should strictly adhere to the treatment regimen prescribed by their doctor and undergo regular check-ups to monitor treatment effectiveness and safety. Pregnant or breastfeeding women should consult a specialist before use.
General data about VIDEX EC 250mg
- Substance: didanosine
- Date of latest medicines list: 01-05-2019
- Product code: W10724001
- Concentration: 250mg
- Pharmaceutical form: gastro-resistant capsules
- Quantity: 30
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for didanosine
Concentrations available for didanosine
- 100mg
- 125mg
- 150mg
- 200mg
- 250mg
- 400mg